ARCHIVES

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.

June 23, 2000

Tobacco Council Announces Awards

September 9, 1977

Study Suggests Surveillance Colonoscopies Overperformed

August 27, 2004

FDA Committee Approves NDA for Mitxantrone

March 21, 1986

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

June 20, 1986

International Research Data Bank Up And Operating Through NLM Systems

September 20, 1974